Ruxolitinib cream for discoid lupus study
Part of Skin clinical trials.
This trial tests a cream (ruxolitinib) on discoid lupus skin lesions. It aims to see if the cream can reduce DLE symptoms in adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have moderate to severe discoid lupus on your skin.
- You cannot be pregnant, breastfeeding, or planning pregnancy.
- You must not have active or latent TB infection.
- You must avoid certain topical treatments 2 weeks before starting.
- You cannot have used certain biologics or JAK inhibitors recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet called dihydroartemisinin to treat discoid lupus erythematosus (DLE), a skin condition where the immune system causes scarring rashes, usually on the face and ears. The study compares this new drug to a standard treatment to see which works better and is safer.
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
This trial tests a cream called ruxolitinib for people with dermatomyositis whose skin symptoms haven't improved with standard treatments. It aims to see if this cream can reduce rash and activity when added to your current medications.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This study tests how well a cream called ruxolitinib works for vitiligo in real-world conditions. It looks at what factors might make the treatment more or less effective.
This study tests whether a cream called ruxolitinib can help children ages 6 to 11 with nonsegmental vitiligo. It aims to see if the cream safely restores color to white patches on the face and body.
Hear when a new Discoid Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.